Shopping Cart 0
Cart Subtotal
USD 0

Biotechnology in Italy

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 350

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 700

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 1050
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Biotechnology in Italy

Summary

Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Italy biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The Italian biotechnology industry had total revenues of USD 9.7bn in 2017, representing a compound annual growth rate (CAGR) of 6.6% between 2013 and 2017.

- The medical/healthcare segment was the industry's most lucrative in 2017, with total revenues of USD 4.0bn, equivalent to 41.7% of the industry's overall value.

- In Italy, there is very little in the way of large biotechnology companies. The industry is dominated by micro and small firms which make up 75% of all companies.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Italy

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Italy

- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Italy biotechnology market with five year forecasts

Reasons to buy

- What was the size of the Italy biotechnology market by value in 2017?

- What will be the size of the Italy biotechnology market in 2022?

- What factors are affecting the strength of competition in the Italy biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up Italy's biotechnology market?

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Category segmentation 2

Geography segmentation 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Category segmentation 10

Geography segmentation 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 15

New entrants 16

Threat of substitutes 18

Degree of rivalry 19

Leading Companies 20

Gentium S.p.A. 20

Menarini Group 21

Zambon Company SpA 22

Macroeconomic Indicators 23

Country data 23

Methodology 25

Industry associations 26

Related MarketLine research 26

Appendix 27

About MarketLine 27


List Of Figure

List of Figures

Figure 1: Italy biotechnology industry value: USD billion, 2013-17

Figure 2: Italy biotechnology industry category segmentation: % share, by value, 2017

Figure 3: Italy biotechnology industry geography segmentation: % share, by value, 2017

Figure 4: Italy biotechnology industry value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the biotechnology industry in Italy, 2017

Figure 6: Drivers of buyer power in the biotechnology industry in Italy, 2017

Figure 7: Drivers of supplier power in the biotechnology industry in Italy, 2017

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Italy, 2017

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Italy, 2017

Figure 10: Drivers of degree of rivalry in the biotechnology industry in Italy, 2017


List Of Table

List of Tables

Table 1: Italy biotechnology industry value: USD billion, 2013-17

Table 2: Italy biotechnology industry category segmentation: USD billion, 2017

Table 3: Italy biotechnology industry geography segmentation: USD billion, 2017

Table 4: Italy biotechnology industry value forecast: USD billion, 2017-22

Table 5: Gentium S.p.A.: key facts

Table 6: Menarini Group: key facts

Table 7: Zambon Company SpA: key facts

Table 8: Italy size of population (million), 2013-17

Table 9: Italy gdp (constant 2005 prices, USD billion), 2013-17

Table 10: Italy gdp (current prices, USD billion), 2013-17

Table 11: Italy inflation, 2013-17

Table 12: Italy consumer price index (absolute), 2013-17

Table 13: Italy exchange rate, 2013-17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Biotechnology in Italy

Summary

Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Italy biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The Italian biotechnology industry had total revenues of USD 9.7bn in 2017, representing a compound annual growth rate (CAGR) of 6.6% between 2013 and 2017.

- The medical/healthcare segment was the industry's most lucrative in 2017, with total revenues of USD 4.0bn, equivalent to 41.7% of the industry's overall value.

- In Italy, there is very little in the way of large biotechnology companies. The industry is dominated by micro and small firms which make up 75% of all companies.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Italy

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Italy

- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Italy biotechnology market with five year forecasts

Reasons to buy

- What was the size of the Italy biotechnology market by value in 2017?

- What will be the size of the Italy biotechnology market in 2022?

- What factors are affecting the strength of competition in the Italy biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up Italy's biotechnology market?

READ MORE

Scope

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Category segmentation 2

Geography segmentation 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Category segmentation 10

Geography segmentation 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 15

New entrants 16

Threat of substitutes 18

Degree of rivalry 19

Leading Companies 20

Gentium S.p.A. 20

Menarini Group 21

Zambon Company SpA 22

Macroeconomic Indicators 23

Country data 23

Methodology 25

Industry associations 26

Related MarketLine research 26

Appendix 27

About MarketLine 27


List Of Figure

List of Figures

Figure 1: Italy biotechnology industry value: USD billion, 2013-17

Figure 2: Italy biotechnology industry category segmentation: % share, by value, 2017

Figure 3: Italy biotechnology industry geography segmentation: % share, by value, 2017

Figure 4: Italy biotechnology industry value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the biotechnology industry in Italy, 2017

Figure 6: Drivers of buyer power in the biotechnology industry in Italy, 2017

Figure 7: Drivers of supplier power in the biotechnology industry in Italy, 2017

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Italy, 2017

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Italy, 2017

Figure 10: Drivers of degree of rivalry in the biotechnology industry in Italy, 2017


List Of Table

List of Tables

Table 1: Italy biotechnology industry value: USD billion, 2013-17

Table 2: Italy biotechnology industry category segmentation: USD billion, 2017

Table 3: Italy biotechnology industry geography segmentation: USD billion, 2017

Table 4: Italy biotechnology industry value forecast: USD billion, 2017-22

Table 5: Gentium S.p.A.: key facts

Table 6: Menarini Group: key facts

Table 7: Zambon Company SpA: key facts

Table 8: Italy size of population (million), 2013-17

Table 9: Italy gdp (constant 2005 prices, USD billion), 2013-17

Table 10: Italy gdp (current prices, USD billion), 2013-17

Table 11: Italy inflation, 2013-17

Table 12: Italy consumer price index (absolute), 2013-17

Table 13: Italy exchange rate, 2013-17

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com
chat_bubbleLet's Chat